Preview

Russian Journal of Gastroenterology, Hepatology, Coloproctology

Advanced search

Evolution of concept of esophageal motor disturbances in pathogenesis of gastroesophageal reflux disease

Abstract

The aim of publication. To present up-to-date data on the role of disorders of motor function of the esophagus in development of gastroesophageal reflux disease and mechanisms of transient lower esophageal sphincter relaxations (TLESR) on functional activity of antireflux barrier.

Original positions. There are several components of TLESR mechanism: decrease of the lower esophageal sphincter pressure, modulated by inhibiting impulses; decrease of compression by crures of diaphragm; intensive contraction of longitudinal muscles of the esophagus; relaxation of circular musculature layer at its distal part. There are differences in TLESR mechanism between healthy persons and patients with gastroesophageal reflux disease (GERD) i.e.: at healthy subjects only gas enters the esophagus from the stomach during TLESR in contrast to patients with reflux disease. Obesity increases potential of TLESR appearance, associated with reflux of liquid contents from the stomach.

Conclusion. Taking into account comprehension of available regulatory parts, reality of influence on esophageal motility and especially LES is tempting. Studying of this function opens encouraging prospects of improvement of treatment of GERD.

About the Authors

V. T. Ivashkin

Russian Federation


A. S. Trukhmanov

Russian Federation


References

1. Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Клинические аспекты функциональной диспепсии и эффективность ганатона (итоприда гидрохлорида) в ее лечении // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2009. – Т. 19, № 6. – С. 17–22.

2. Маев И.В., Самсонов А.А., Одинцова А.Н. Перспективы применения нового прокинетика с двойным механизмом действия в терапии гастроэзофагеальной рефлюксной болезни // Фарматека. – 2009. – № 2. – С. 1–5.

3. Минушкин О.Н., Лощинина Ю.Н. Эффективность применения препарата Ганатон в лечении больных ГЭРБ // Эффективная фармакотерапия в гастроэнтерологии и гепатологии. – 2008. – № 3. – С. 20–24.

4. Asling B., Jirholt J., Hammond P. et al. Collagen type III alpha I is a gastroesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia // Gut. – 2009. – Vol. 58. – P. 1063–1069.

5. Boeckxstaens G.E. Review article: the pathophysiology of gastroesophageal reflux disease // Aliment. Pharmacol. Ther. – 2007. – Vol. 26. – P. 149–160.

6. Dent J. Pathogenesis of gastroesophageal reflux disease and novel options for its therapy // Neurogastroenterol. Motil. – 2008. – Vol. 20 (suppl. 1). – P. 91–102.

7. Dent J., Holloway R.H., Toouli J., Dodds W.J. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux // Gut. – 1988. – Vol. 29. – P. 1020–1028.

8. Inoue K. et al. Effect of itopride hydrochloride on the digestive symptoms of chronic gastritis with reflux esophagitis // Clin. Med. – 1999. – Vol. 15, N 11. – P. 1803–1809.

9. Kahrilas P.J., Shi G., Manka M., Joehl R.J. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia // Gastroenterology. – 2000. – Vol. 118. – P. 688–695.

10. Kim Y.S. et al. Effect of itopride, a new procinetic, in patients with mild GERD: A pilot study // World J. Gastroenterol. – 2005. – Vol. 11, N 27. – P. 4210–4214.

11. Mittal R.K., Holioway R.H., Penagini R. et al. Transient lower esophageal sphincter relaxation // Gastroenterology. – 1995. – Vol. 109. – P. 601–610.

12. Modlin I.M., Hunt R.H., Malfertheiner P. et al. Nonerosive reflux disease – defining the entity and delineating the management // Digestion. – 2008. – Vol. 78 (suppl 1). – P. 1–5.

13. Pandolfino J.E., Zhang Q.G., Ghosh S.K. et al. Transient lower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry // Gastroenterology. – 2006. – Vol. 131. – P. 1725–1733.

14. Sawant P., Kalokhe S., Patil S. Itopride: A new armamentarium for the management of gastric motility disorders // Gastroenterology Today. – 2002. – Vol. 6. – P. 1–6.

15. Sifrim D., Holloway R. Transient lower esophageal sphincter relaxations: how many or how harmful? // Am. J. Gastroenterol. – 2001. – Vol. 96. – P. 2529–2532.

16. Sifrim D., Holloway R., Silny J. et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease // Am. J. Gastroenterol. – 2001. – Vol. 96. – P. 647–655.

17. Wu J.C., Mui L.M., Cheung C.M. et al. Obesity is associated with increased transient lower esophageal sphincter relaxation // Digestion. – 2007. – Vol. 132, N 3. – P. 883–889.

18. Wyman J.B., Dent J., Heddle R. et al. Control of belching by the lower esophageal sphincter // Gut. – 1990. – Vol. 31. – P. 639–646.


Review

For citations:


Ivashkin V.T., Trukhmanov A.S. Evolution of concept of esophageal motor disturbances in pathogenesis of gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2010;20(2):13-19. (In Russ.)

Views: 58


ISSN 1382-4376 (Print)
ISSN 2658-6673 (Online)